Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in Recurred or Metastatic Adenoid Cystic Carcinoma
NCT02859012Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in adenoid cystic carcinoma (ACC), sponsored by Seoul National University Hospital. Started Sep 2016; status: completed.
02
Drugs
axitinib
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT02859012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859012.